CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Position in MRNA — Moderna, Inc.
CIK 884546
SAN FRANCISCO, CA
Position in MRNA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$338,867,045
+$98,361,761 QoQ
Shares Held
4,838,884
+2.2% QoQ
Ownership
1.21%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#14
of 772 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MRNA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $7,346,663,053 across 299 Biotechnology names. MRNA ranks #4 (4.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,041,282 | $1,013,966,007 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
846,306 | $527,705,642 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
1,917,025 | $359,020,441 | |
| 4 | MRNA |
Moderna, Inc.
This page
|
4,838,884 | $338,867,045 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
755,377 | $227,391,137 | |
| 6 | INCY |
Incyte Corp
|
1,692,439 | $191,854,884 | |
| 7 | RPRX |
Royalty Pharma plc
|
3,083,528 | $172,893,414 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,565,781 | $133,388,883 |
All Filings in MRNA
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $338,867,045 | 4,838,884 | Shares | Other | 2026-08-14 | |
| 2026-03-31 | $240,505,284 | 4,734,356 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $136,289,745 | 4,621,558 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $111,390,118 | 4,312,432 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $83,876,828 | 3,040,117 | Shares | Sole | 2025-08-12 | |
| 2024-12-31 | $97,471,960 | 2,344,203 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $142,533,486 | 2,132,777 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $243,401,281 | 2,049,695 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $209,666,283 | 1,967,589 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $186,110,630 | 1,871,399 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $186,028,491 | 1,801,031 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $212,889,870 | 1,752,180 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $275,262,509 | 1,792,307 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $315,855,124 | 1,758,463 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $206,894,811 | 1,749,639 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $233,640,031 | 1,635,562 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $279,670,483 | 1,623,537 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $399,633,974 | 1,573,486 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $591,843,865 | 1,537,816 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $189,809,089 | 807,767 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $102,291,068 | 781,146 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $76,779,495 | 734,943 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $50,693,790 | 716,520 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $93,490,723 | 1,456,015 | Shares | Sole | 2020-08-20 | |
| 2020-03-31 | $30,485,356 | 1,017,875 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||